BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
FRANKLIN LAKES, N.J., Sept. 12, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to detect rare molecules responsible for biological diversity that are often missed with whole transcriptome profiling. Developed using the company’s... Read more